CHEMBL346994,
656827-86-0,
1H-PYRAZOLE-1-CARBOXIMIDAMIDE, 3-(4-CHLOROPHENYL)-N-[(4-CHLOROPHENYL)SULFONYL]-4,5-DIHYDRO-N'-METHYL-4-PHENYL-, (4R)-,
C23H20Cl2N4O2S,
SCHEMBL8140161,
CTK5C2990,
DTXSID00463595,
HMS3650M16,
1373AH,
BDBM50138913,
ZINC13559250,
SR-01000946307,
SR-01000946307-1,
(4s)-3-(4-chlorophenyl)-n-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-n'-methyl-4-phenyl-1h-pyrazole-1-carboximidamide,
3-(4-Chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-4,5-dihydro-N'-methyl-4R-phenyl-1H-pyrazole-1-carboximidamide,
4-Chloro-N-[1-[(R)-3-(4-chloro-phenyl)-4-phenyl-4,5-dihydro-pyrazol-1-yl]-1-methylamino-meth-(E)-ylidene]-benzenesulfonamide,
Ibipinabant,
-SLV319,
AXJQVVLKUYCICH-NRFANRHFSA-N,
CID 9826744,
CID11363773,
(4R)-5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl,
464213-10-3,